NSTM
NOVELSTEM INTL CORP by NovelStem International Corp. (NSTM)
$01
About NOVELSTEM INTL CORP by NovelStem International Corp. (NSTM)
NovelStem International Corp. develops novel diagnostic technology that can predict patients resistance to chemotherapy allowing for cancer treatments and the potential to reduce resistance to chemotherapy. The company was founded by Mitchell Rubenstein and Laurie S. Silvers on January 22, 1993 and is headquartered in Boca Raton, FL.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.07
52 Week Low
$0.01
Market cap
379,700
Dividend yield
0.00%
Volume
--
Avg. volume
8,213
P/E ratio
-.08
NOVELSTEM INTL CORP by NovelStem International Corp. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.07
52 Week Low
$0.01
Market cap
379,700
Dividend yield
0.00%
Volume
--
Avg. volume
8,213
P/E ratio
-.08